{"id":395007,"date":"2021-12-02T10:57:29","date_gmt":"2021-12-02T13:57:29","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=395007"},"modified":"2021-12-02T10:57:29","modified_gmt":"2021-12-02T13:57:29","slug":"reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/","title":{"rendered":"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Londres.-<\/strong><\/em> La agencia brit\u00e1nica de medicamentos (MHRA) anunci\u00f3 hoy que aprob\u00f3 el tratamiento del laboratorio local GlaxoSmithKline (GSK) contra el coronavirus a base de anticuerpos monoclonales de larga duraci\u00f3n, un f\u00e1rmaco que seg\u00fan la compa\u00f1\u00eda sirve contra la nueva variante \u00f3micron.<!--more--><\/p>\n<p style=\"text-align: justify;\">El sotrovimab, nombre del medicamento, se revel\u00f3 \u00abseguro y eficaz para reducir los riesgos de hospitalizaci\u00f3n y de muerte en las personas con covid-19 de leve a moderado y con riesgo grave de desarrollar una forma grave de la enfermedad\u00bb, inform\u00f3 el MHRA en un comunicado que fue recogido por la agencia de noticias AFP.<\/p>\n<p style=\"text-align: justify;\">GSK dijo por su parte que el tratamiento, que es inyectable, serv\u00eda contra las mutaciones claves de la nueva variante \u00d3micron.<\/p>\n<p style=\"text-align: justify;\">\u00abActualmente, el sotrovimab demostr\u00f3 que actuaba contra todas las variantes preocupantes y de inter\u00e9s definidas por la Organizaci\u00f3n Mundial de la Salud (OMS)\u00bb, dijo el laboratorio.<\/p>\n<p style=\"text-align: justify;\">Seg\u00fan la MHRA, una sola dosis del medicamento puede reducir el riesgo de hospitalizaci\u00f3n y de muerte en un 79% en adultos de alto riesgo contagiados y con s\u00edntomas.<\/p>\n<p style=\"text-align: justify;\">El medicamento fue desarrollado en asociaci\u00f3n con el laboratorio californiano Vir Biotechnology.<\/p>\n<p style=\"text-align: justify;\">A finales de junio, la Comisi\u00f3n Europea calific\u00f3 el tratamiento como uno de los cinco m\u00e1s prometedores contra el coronavirus.<\/p>\n<p style=\"text-align: justify;\">El sotrovimab es el segundo tratamiento contra el coronavirus aprobado en un mes por el Reino Unido, despu\u00e9s del molnupiravir, comprimidos del laboratorio estadounidense Merck, que recibi\u00f3 luz verde en noviembre.T\u00e9lam<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Londres.- La agencia brit\u00e1nica de medicamentos (MHRA) anunci\u00f3 hoy que aprob\u00f3 el tratamiento del laboratorio local GlaxoSmithKline (GSK) contra el coronavirus a base de anticuerpos monoclonales de larga duraci\u00f3n, un f\u00e1rmaco que seg\u00fan la compa\u00f1\u00eda sirve contra la nueva variante \u00f3micron.<\/p>\n","protected":false},"author":23,"featured_media":395013,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5],"tags":[2992,9831,3463,9837,9886],"class_list":["post-395007","post","type-post","status-publish","format-standard","has-post-thumbnail","category-internacionales","tag-coronavirus","tag-omicron","tag-reino-unido","tag-variante-omicron","tag-vir-biotechnology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Londres.- La agencia brit\u00e1nica de medicamentos (MHRA) anunci\u00f3 hoy que aprob\u00f3 el tratamiento del laboratorio local GlaxoSmithKline (GSK) contra el coronavirus a base de anticuerpos monoclonales de larga duraci\u00f3n, un f\u00e1rmaco que seg\u00fan la compa\u00f1\u00eda sirve contra la nueva variante \u00f3micron.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-02T13:57:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/GlaxoSmithKline.png\" \/>\n\t<meta property=\"og:image:width\" content=\"690\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Noelia Ferreira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Noelia Ferreira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/\"},\"author\":{\"name\":\"Noelia Ferreira\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\"},\"headline\":\"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron\",\"datePublished\":\"2021-12-02T13:57:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/\"},\"wordCount\":265,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/GlaxoSmithKline.png\",\"keywords\":[\"coronavirus\",\"\u00d3micron\",\"Reino Unido\",\"Variante Omicr\u00f3n\",\"Vir Biotechnology\"],\"articleSection\":[\"Internacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/\",\"name\":\"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/GlaxoSmithKline.png\",\"datePublished\":\"2021-12-02T13:57:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/GlaxoSmithKline.png\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/GlaxoSmithKline.png\",\"width\":690,\"height\":450,\"caption\":\"Foto: Gentileza\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2021\\\/12\\\/02\\\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/LOGO-ip-mobile.png\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/LOGO-ip-mobile.png\",\"width\":140,\"height\":44,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/791af27a9219bdbf9064abb776bb41c2\",\"name\":\"Noelia Ferreira\",\"sameAs\":[\"http:\\\/\\\/www.ip.gov.py\"],\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/nferreira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/","og_locale":"es_ES","og_type":"article","og_title":"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron - .::Agencia IP::.","og_description":"Londres.- La agencia brit\u00e1nica de medicamentos (MHRA) anunci\u00f3 hoy que aprob\u00f3 el tratamiento del laboratorio local GlaxoSmithKline (GSK) contra el coronavirus a base de anticuerpos monoclonales de larga duraci\u00f3n, un f\u00e1rmaco que seg\u00fan la compa\u00f1\u00eda sirve contra la nueva variante \u00f3micron.","og_url":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2021-12-02T13:57:29+00:00","og_image":[{"width":690,"height":450,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/GlaxoSmithKline.png","type":"image\/png"}],"author":"Noelia Ferreira","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"Noelia Ferreira","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/"},"author":{"name":"Noelia Ferreira","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2"},"headline":"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron","datePublished":"2021-12-02T13:57:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/"},"wordCount":265,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/GlaxoSmithKline.png","keywords":["coronavirus","\u00d3micron","Reino Unido","Variante Omicr\u00f3n","Vir Biotechnology"],"articleSection":["Internacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/","url":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/","name":"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/GlaxoSmithKline.png","datePublished":"2021-12-02T13:57:29+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/GlaxoSmithKline.png","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2021\/12\/GlaxoSmithKline.png","width":690,"height":450,"caption":"Foto: Gentileza"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2021\/12\/02\/reino-unido-aprueba-tratamiento-que-dice-ser-efectivo-contra-la-variante-omicron\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Reino Unido aprueba tratamiento que dice ser efectivo contra la variante \u00f3micron"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2019\/03\/LOGO-ip-mobile.png","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2019\/03\/LOGO-ip-mobile.png","width":140,"height":44,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/791af27a9219bdbf9064abb776bb41c2","name":"Noelia Ferreira","sameAs":["http:\/\/www.ip.gov.py"],"url":"https:\/\/www.ip.gov.py\/ip\/author\/nferreira\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/395007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=395007"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/395007\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/395013"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=395007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=395007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=395007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}